Neuromuscular Disorders
Volume 16, Issue 6 , Pages 403-413 , June 2006

140th ENMC International Workshop: Myotonic Dystrophy DM2/PROMM and other myotonic dystrophies with guidelines on management

To the memory of Dr Ken Ricker

Received 9 March 2006 ,Revised 9 March 2006 ,Accepted 16 March 2006.

References 

  1. Harper PS. Myotonic dystrophy. 2nd ed. London: W.B. Saunders; 1989;
  2. Thornton CA, Griggs RC, Moxley RT. Myotonic dystrophy with no trinucleotide repeat expansion [see comments]. Ann Neurol. 1994;35(3):269–272
  3. Ricker K, Koch MC, Lehmann-Horn F, et al. Proximal myotonic myopathy: a new dominant disorder with myotonia, muscle weakness, and cataracts. Neurology. 1994;44(8):1448–1452
  4. Moxley RT, Udd B, Ricker K. Proximal myotonic myopathy (PROMM) and other proximal myotonic syndromes. Neuromuscul Disord. 1998;8(7):519–520
  5. Ranum LP, Rasmussen PF, Benzow KA, Koob MD, Day JW. Genetic mapping of a second myotonic dystrophy locus. Nat Genet. 1998;19(2):196–198
  6. The International Myotonic Dystrophy Consortium (IDMC). New nomenclature and DNA testing guidelines for myotonic dystrophy type 1. Neurology. 2000;54:1218–1221
  7. Udd B, Krahe R, Wallgren-Pettersson C, Falck B, Kalimo H. Proximal myotonic dystrophy—a family with autosomal dominant muscular dystrophy, cataracts, hearing loss and hypogonadism: heterogeneity of proximal myotonic syndromes?. Neuromuscul Disord. 1997;7(4):217–228
  8. Bachinski L, Udd B, Meola G, et al. Verification of DM2 (CCTG)n expansion mutation and a single shared haplotype among PROMM/PDM patients from different ethnic origins indicates ancestral founder effect. Am J Hum Gen. 2003;78:835–848
  9. Liquori CL, Ricker K, Moseley ML, et al. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science. 2001;293(5531):864–867
  10. Moxley R, Meola G, Udd B, Ricker K. 84th ENMC: Proximal myotonic myopathy (PROMM) and other myotonic dystrophy like syndromes. Neuromuscul Disord. 2002;12:306–317
  11. Udd B, Meola G, Krahe R, et al. 115th ENMC: DM2/PROMM and other myotonic dystrophies: 3rd workshop. Neuromuscul Disord. 2003;13:589–596
  12. Liquori CL, Ikeda Y, Weatherspoon M, Ricker K, et al. Myotonic dystrophy type 2: human founder haplotype and consercation of the repeat tract. Am J Hum Genet. 2003;73:849–862
  13. Jakubiczka S, Vielhaber S, Kress W, et al. Improvement of the diagnostic procedure in PROMM/DM2. Neurogenetics. 2004;5:55–59
  14. Sallinen R, Vihola A, Bachinski L, et al. New methods for molecular diagnosis and demonstration of the (CCTG)n mutation in myotonic dystrophy type 2 (DM2). Neuromuscul Disord. 2004;14:274–283
  15. Serratrice J, Weiller PJ, Pouget J, Serratrice G. An unrecognized cause of camptocormia: proximal myotonic myopathy. Presse Med. 2000;29(20):1121–1123
  16. Wright RB, Glantz RH, Butcher J. Hearing loss in myotonic dystrophy. Ann Neurol. 1988;23(2):202–203
  17. Schoser B, Kress W, Walter M, Halliger-Keller B, Lochmüller H, Ricker K. Homozygosity for CCTG mutation in myotonic dystrophy type 2. Brain. 2004;127:1187–1868
  18. Schneider-Gold C, Beer M, Kostler H, et al. Cardiac and skeletal muscle involvement in myotonic dystrophy type 2 (DM2): a quantitative 31P-MRS and MRI study. Muscle Nerve. 2004;30:636–644
  19. Schoser B, Ricker K, Schneider-Gold C, et al. Sudden cardiac death in myotonic dystrophy type 2. Neurology. 2004;63:2402–2404
  20. Meola G, Sansone V, Perani D, et al. Executive dysfunction and avoidant personality trait in myotonic dystrophy type 1 (DM1) and in PROMM/DM2. Neuromuscul Disord. 2003;13:813–821
  21. Sansone V, Meola G, Perani D, et al. Glucose metabolism and dopamine PET correlate in a patient with myotonic dystrophy type 2 and parkinsonism. J Neurol Neurosurg Psychiatry. 2006;77:425–426
  22. Maurage CA, Udd B, Ruchoux MM, et al. Similar brain Tau pathology in DM2/PROMM and DM1/Steinert's disease. Neurology. 2005;65:1636–1638
  23. Vihola A, Bassez G, Meola G, et al. Histopathological differences of myotonic dystrophy type 1 (DM1) and PROMM/DM2. Neurology. 2003;60:1854–1857
  24. Mankodi A, Teng-Umnuay P, Krym P, et al. Ribonuclear inclusions in skeletal muscle in myotonic dystrophy types 1 and 2. Ann Neurol. 2003;54:760–768
  25. Jiang H, Mankodi A, Swanson MS, et al. Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons. Hum Mol Genet. 2004;13:3079–3088
  26. Kanadia R, Johnstone K, Mankodi A, et al. A muscleblind knockout model for myotonic dystrophy. Science. 2003;302:1978–1980
  27. Ranum LP, Day JW. Myotonic dystrophy: RNA pathogenesis comes into focus. Am J Hum Genet. 2004;74:793–804
  28. Botta A, Caldarola S, Vallo L, et al. Effect of the [CCTG](n) repeat expansion on ZNF9 expression in myotonic dystrophy type II (DM2). Biochim Biophys Acta. 2005;December 6:[Epub ahead of print]
  29. Timchenko N, Patel R, Iakova P, et al. Overexpression of CUG triplet repeat-binding protein, CUGBP1, in mice inhibits myogenesis. J Biol Chem. 2004;279:13129–13139
  30. Mankodi A, Logigian E, Callahan L, et al. Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. Science. 2000;289:1769–1773
  31. Le Ber I, Martinez M, Campion D, et al. A non-DM1, non DM2 multisystemic myotonic disorder with frontotemporal dementia: phenotype and suggestive mapping of the DM3 locus to chr 15q22-24. Brain. 2004;127:1979–1992
  32. Watts GDJ, Wymer J, Kovach MJ, et al. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet. 2004;36:377–381[and supplementary web-based material]

☆ The ENMC consortium on myotonic dystrophy type 2 (=DM2/PROMM) held its 4th workshop in Naarden, The Netherlands, 20–22th March 2006. It was attended by 21 active participants from Finland, France, Germany, Italy, Spain, and the USA. The workshop opened with a memorial to honor the past pioneer in the field: Dr Kenneth Ricker and his extensive clinical work on DM2 and other myotonic disorders.

PII: S0960-8966(06)00097-6

doi: 10.1016/j.nmd.2006.03.010

Neuromuscular Disorders
Volume 16, Issue 6 , Pages 403-413 , June 2006

Article Tools